US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist
  • 1.010
  • -0.020-1.94%
Trading Mar 25 10:15 ET
62.97MMarket Cap-2.81P/E (TTM)

Cytosorbents Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
11.08%8.61M
9.53%8.84M
13.65%8.99M
5.88%31.08M
-3.84%7.35M
19.98%7.75M
10.12%8.07M
-0.18%7.91M
-26.80%29.36M
-21.20%7.64M
Operating revenue
11.08%8.61M
9.53%8.84M
13.65%8.99M
5.88%31.08M
-3.84%7.35M
19.98%7.75M
10.12%8.07M
-0.18%7.91M
-26.80%29.36M
-21.20%7.64M
Cost of revenue
28.24%4.11M
-0.30%3.39M
-19.49%3.22M
0.01%13.96M
-7.61%3.36M
-28.70%3.2M
-4.18%3.4M
75.36%3.99M
26.33%13.96M
16.35%3.63M
Gross profit
-1.01%4.5M
16.70%5.45M
47.45%5.77M
11.19%17.13M
-0.42%3.99M
131.12%4.55M
23.55%4.67M
-30.65%3.92M
-46.99%15.4M
-39.03%4.01M
Operating expense
-25.21%8.9M
-21.02%8.87M
-9.39%10.7M
3.01%48.34M
28.64%13.33M
8.32%11.9M
-7.48%11.23M
-12.13%11.81M
-9.42%46.93M
-35.77%10.36M
Selling and administrative expenses
-15.00%7.83M
-5.69%8.4M
1.26%9.25M
1.98%37.87M
21.18%10.56M
-1.46%9.21M
-2.30%8.91M
-8.32%9.13M
-3.50%37.14M
-21.40%8.71M
-General and administrative expense
-15.00%7.83M
-5.69%8.4M
1.26%9.25M
1.98%37.87M
21.18%10.56M
-1.46%9.21M
-2.30%8.91M
-8.32%9.13M
-3.50%37.14M
-21.40%8.71M
Research and development costs
-50.62%1.85M
-58.58%1.52M
-46.65%2.25M
4.03%15.73M
20.42%4.1M
13.95%3.75M
-12.30%3.67M
-0.68%4.21M
-7.70%15.12M
-44.57%3.4M
Other operating expenses
26.42%-777.59K
21.92%-1.05M
48.24%-796.77K
1.21%-5.26M
24.52%-1.32M
35.90%-1.06M
-15.76%-1.35M
-100.72%-1.54M
-74.32%-5.33M
-61.25%-1.75M
Operating profit
40.19%-4.4M
47.88%-3.42M
37.59%-4.93M
0.99%-31.21M
-46.96%-9.34M
18.49%-7.35M
21.51%-6.56M
-1.29%-7.89M
-38.59%-31.52M
33.52%-6.36M
Net non-operating interest income expense
-1,646.82%-588.15K
-1,941.70%-180.1K
89.47%-6.65K
-219.08%-157.89K
-197.17%-52.23K
-171.88%-33.67K
-136.80%-8.82K
-886.97%-63.17K
373.44%132.6K
337.19%53.75K
Non-operating interest expense
1,646.82%588.15K
----
----
----
----
--33.67K
----
----
----
----
Total other finance cost
----
1,941.70%180.1K
-89.47%6.65K
219.08%157.89K
----
----
136.80%8.82K
886.97%63.17K
-373.44%-132.6K
-337.19%-53.75K
Other net income (expense)
246.45%2.65M
-231.15%-544.23K
-326.70%-1.43M
181.32%2.05M
-38.23%2.75M
43.98%-1.81M
116.30%414.97K
153.15%628.88K
2.41%-2.52M
1,000.51%4.44M
Gain on sale of security
246.45%2.65M
-231.15%-544.23K
-315.79%-1.43M
179.61%1.95M
-40.61%2.68M
43.98%-1.81M
116.45%414.97K
154.45%660.68K
5.02%-2.45M
1,015.53%4.52M
Other non- operating income (expenses)
----
----
----
243.76%96.75K
183.30%61.75K
----
----
-205.99%-31.8K
---67.3K
---74.13K
Income before tax
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
13.52%-29.32M
-257.70%-6.65M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-34.04%-33.91M
81.49%-1.86M
Income tax
0
0
0
25.52%-813.74K
25.52%-813.74K
0
0
0
-48.45%-1.09M
-48.45%-1.09M
Net income
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
Net income continuous Operations
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
Minority interest income
Net income attributable to the parent company
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
Basic earnings per share
80.95%-0.0398
42.86%-0.0796
29.41%-0.1194
14.67%-0.6368
-1,100.06%-0.1194
25.00%-0.209
44.00%-0.1393
19.05%-0.1692
-31.58%-0.7463
95.24%-0.01
Diluted earnings per share
80.95%-0.0398
42.86%-0.0796
29.41%-0.1194
14.67%-0.6368
-1,100.06%-0.1194
25.00%-0.209
44.00%-0.1393
19.05%-0.1692
-31.58%-0.7463
95.24%-0.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 11.08%8.61M9.53%8.84M13.65%8.99M5.88%31.08M-3.84%7.35M19.98%7.75M10.12%8.07M-0.18%7.91M-26.80%29.36M-21.20%7.64M
Operating revenue 11.08%8.61M9.53%8.84M13.65%8.99M5.88%31.08M-3.84%7.35M19.98%7.75M10.12%8.07M-0.18%7.91M-26.80%29.36M-21.20%7.64M
Cost of revenue 28.24%4.11M-0.30%3.39M-19.49%3.22M0.01%13.96M-7.61%3.36M-28.70%3.2M-4.18%3.4M75.36%3.99M26.33%13.96M16.35%3.63M
Gross profit -1.01%4.5M16.70%5.45M47.45%5.77M11.19%17.13M-0.42%3.99M131.12%4.55M23.55%4.67M-30.65%3.92M-46.99%15.4M-39.03%4.01M
Operating expense -25.21%8.9M-21.02%8.87M-9.39%10.7M3.01%48.34M28.64%13.33M8.32%11.9M-7.48%11.23M-12.13%11.81M-9.42%46.93M-35.77%10.36M
Selling and administrative expenses -15.00%7.83M-5.69%8.4M1.26%9.25M1.98%37.87M21.18%10.56M-1.46%9.21M-2.30%8.91M-8.32%9.13M-3.50%37.14M-21.40%8.71M
-General and administrative expense -15.00%7.83M-5.69%8.4M1.26%9.25M1.98%37.87M21.18%10.56M-1.46%9.21M-2.30%8.91M-8.32%9.13M-3.50%37.14M-21.40%8.71M
Research and development costs -50.62%1.85M-58.58%1.52M-46.65%2.25M4.03%15.73M20.42%4.1M13.95%3.75M-12.30%3.67M-0.68%4.21M-7.70%15.12M-44.57%3.4M
Other operating expenses 26.42%-777.59K21.92%-1.05M48.24%-796.77K1.21%-5.26M24.52%-1.32M35.90%-1.06M-15.76%-1.35M-100.72%-1.54M-74.32%-5.33M-61.25%-1.75M
Operating profit 40.19%-4.4M47.88%-3.42M37.59%-4.93M0.99%-31.21M-46.96%-9.34M18.49%-7.35M21.51%-6.56M-1.29%-7.89M-38.59%-31.52M33.52%-6.36M
Net non-operating interest income expense -1,646.82%-588.15K-1,941.70%-180.1K89.47%-6.65K-219.08%-157.89K-197.17%-52.23K-171.88%-33.67K-136.80%-8.82K-886.97%-63.17K373.44%132.6K337.19%53.75K
Non-operating interest expense 1,646.82%588.15K------------------33.67K----------------
Total other finance cost ----1,941.70%180.1K-89.47%6.65K219.08%157.89K--------136.80%8.82K886.97%63.17K-373.44%-132.6K-337.19%-53.75K
Other net income (expense) 246.45%2.65M-231.15%-544.23K-326.70%-1.43M181.32%2.05M-38.23%2.75M43.98%-1.81M116.30%414.97K153.15%628.88K2.41%-2.52M1,000.51%4.44M
Gain on sale of security 246.45%2.65M-231.15%-544.23K-315.79%-1.43M179.61%1.95M-40.61%2.68M43.98%-1.81M116.45%414.97K154.45%660.68K5.02%-2.45M1,015.53%4.52M
Other non- operating income (expenses) ------------243.76%96.75K183.30%61.75K---------205.99%-31.8K---67.3K---74.13K
Income before tax 74.61%-2.33M32.67%-4.14M13.21%-6.36M13.52%-29.32M-257.70%-6.65M24.65%-9.19M43.44%-6.15M18.30%-7.33M-34.04%-33.91M81.49%-1.86M
Income tax 00025.52%-813.74K25.52%-813.74K000-48.45%-1.09M-48.45%-1.09M
Net income 74.61%-2.33M32.67%-4.14M13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K
Net income continuous Operations 74.61%-2.33M32.67%-4.14M13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K
Minority interest income
Net income attributable to the parent company 74.61%-2.33M32.67%-4.14M13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 74.61%-2.33M32.67%-4.14M13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K
Basic earnings per share 80.95%-0.039842.86%-0.079629.41%-0.119414.67%-0.6368-1,100.06%-0.119425.00%-0.20944.00%-0.139319.05%-0.1692-31.58%-0.746395.24%-0.01
Diluted earnings per share 80.95%-0.039842.86%-0.079629.41%-0.119414.67%-0.6368-1,100.06%-0.119425.00%-0.20944.00%-0.139319.05%-0.1692-31.58%-0.746395.24%-0.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+3.69%
Ecopetrol
EC
+2.48%
Vale SA
VALE
+1.86%
Meta Platforms
META
+1.25%
Adobe
ADBE
+1.18%

Unlock the Full List